نتائج البحث 321-330 من 11787 لعملية البحث عن Assay
... assays using patient peripheral blood immune cells or serum. Evaluate REC-4881 in Patients With FAP (TUPELO). Scottsdale/Phoenix, Ariz., Rochester, Minn. The ...
The performance characteristics of these assays for detecting ctDNA mutation in oncology patients will be assessed by comparing the mutation results obtained ...
This will be accomplished by utilizing the the immunoSEQ Human T-cell Receptor Beta (hsTCB) Assay (Adaptive Biothechnologies) and the publicly available ...
Rochester, Minn. The purporse of this study is to determine if biomarker assay obtained at baseline can predict future risk of cardiovascular adverse events, ...
Eligible participants with mCRC will be enrolled into specific treatment arms based on their biomarker assay results. A Study to Evaluate the Effectiveness ...
... assayed from blood of cases with CAP and controls without history of cancer. DALY 2.0 USA/ MB-CART2019.1 for DLBCL. Scottsdale/Phoenix, Ariz., Rochester ...
... assay (IHC) and identified as appropriate for study participation if IHC staining is PS2+ in \>75% of cells (40% of all serous patients). Eligible patients ...
The purporse of this study is to determine if biomarker assay obtained at baseline can predict future risk of cardiovascular adverse events, ...
لا تُقدم Mayo Clinic الدعم للشركات أو المنتجات المُعلَّن عنها هنا. لكن تدعم العائدات الإعلانية رسالتنا غير الربحية.
تحقق من هذه الكتب الأكثر مبيعًا والعروض الخاصة على الكتب والنشرات الإخبارية من Mayo Clinic Press.
تساهم التبرّعات، وهي قابلة للخصم الضريبي، في دعم آخر التطورات في الأبحاث وطرق الرعاية لإحداث نقلة نوعية في الطب.